Loading clinical trials...

Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL) | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 3NCT00117598

Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)

This is an open-label, randomized trial in relapsed refractory subjects with mantle cell lymphoma (MCL).

Lead sponsor: Pfizer•19 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Pfizer

Related studies

A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy

NCT07249528 · Non-hodgkin Lymphoma, Multiple Myeloma

RECRUITINGPhase 2

A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

NCT04570423 · Solid Tumors, Lymphoma

Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies

NCT00131014 · Non-Hodgkin's Lymphoma, Hodgkin's Disease, and more

Familial Investigations of Childhood Cancer Predisposition

NCT03050268 · Acute Leukemia, Adenomatous Polyposis, and more

RECRUITINGPhase 2

Clinical Study of XNW5004 Tablets in the Treatment of Relapsed and Refractory Follicular Lymphoma

NCT07545603 · Follicular Lymphoma, Grade 1, Follicular Lymphoma, Grade 2, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 30, 2015Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment169

Start dateMay 2005

Last updatedMar 30, 2015

Condition

Locations shown

Pfizer Investigational Site

Little Rock, Arkansas

Pfizer Investigational Site

Fountain Valley, California

Pfizer Investigational Site

Los Angeles, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 30, 2015Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions